Blue Marble Biomaterials, a specialty biochemical manufacturer (earlier post), has closed on the purchase of the former GTC Oats Inc. facility in Missoula, Montana. The site, previously a wet extraction processing plant for the creation of food ingredients, will become Blue Marble’s first large-scale commercial biorefinery.
Blue Marble uses novel bacterial consortia to produce specialty biochemicals from the anaerobic fermentation of a range of biomass feedstocks.
The purchase includes 3.81 acres of land, a 19,000 square foot building complex, and parking stalls for more than 100 employees. The building retrofits will include systems that will allow for greater energy efficiency and enable the site to be a showcase for the company’s “zero-waste” focus.
Blue Marble Biomaterials expects to see significant growth in the coming months, as the site purchase comes just as Blue Marble begins closing a $15-million debt financing deal through the USCIS EB-5 Program. The EB-5 Program was created by Congress in 1990 as a mechanism to stimulate economic activity, encourage foreign investment in US companies, and create domestic jobs.
Currently employing 24 people, Blue Marble Biomaterials is one of the first biotechnology companies to take advantage of the program and expects to create over 300 direct and indirect jobs in the Missoula area as a result of the financing and recent site purchase.